Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro, Zepbound Sales Double - Investor's Business Daily
Source:Investor's Business Daily
While Novo Nordisk is calling for a sales downfall in 2026, Eli Lilly is more upbeat.
While Novo Nordisk is calling for a sales downfall in 2026, Eli Lilly is more upbeat.